2745 A comparison of overall survival (OS) between 40 and 50mg/m2 pegylated liposomal doxorubicin (PLD) in recurrent epithelial ovarian cancer (OC) patients (pts): Propensity score (ProS) matched analysis of real world data
2016 ◽
Vol 143
(2)
◽
pp. 246-251
◽
2003 ◽
Vol 1
(5)
◽
pp. S51
◽
Keyword(s):
2020 ◽
Keyword(s):
2021 ◽
Vol 21
◽
pp. S444-S445
Keyword(s):
2020 ◽
Vol 20
(10)
◽
pp. 704-711